These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 308223

  • 1. New treatment for patients with iron overload.
    Griffith P, Burks J.
    J Nurs Care; 1978 Sep; 11(9):12-4. PubMed ID: 308223
    [No Abstract] [Full Text] [Related]

  • 2. The effect of treatment with long-term chelating agents on iron overload in thalassaemia.
    Letsky EA, Flynn DM, Barry M.
    Br J Haematol; 1973 Aug; 25(2):285. PubMed ID: 4726921
    [No Abstract] [Full Text] [Related]

  • 3. The development of new drugs for use in iron chelation therapy.
    Grady RW.
    Birth Defects Orig Artic Ser; 1976 Aug; 12(8):161-75. PubMed ID: 795480
    [No Abstract] [Full Text] [Related]

  • 4. Chelation therapy in beta-thalassemia major: a one-year double blind study of 2,3-dihydroxybenzoic acid.
    Peterson CM, Graziano JH, Grady RW, Jones RL, Markenson A, Lavi U, Canale V, Gray GF, Cerami A, Miller DR.
    Exp Hematol; 1979 Feb; 7(2):74-80. PubMed ID: 371974
    [Abstract] [Full Text] [Related]

  • 5. Thalassemia in Italy: treatment of Cooley disease and iron kinetics in heterozygotes.
    Rotoli B.
    Birth Defects Orig Artic Ser; 1976 Feb; 12(8):53-61. PubMed ID: 1009235
    [Abstract] [Full Text] [Related]

  • 6. Treatment of iron overload in Cooley's anemia.
    Cohen A, Mizanin J, Schwartz E.
    Ann N Y Acad Sci; 1985 Feb; 445():274-81. PubMed ID: 3860130
    [No Abstract] [Full Text] [Related]

  • 7. Thalassemia.
    Brown EB.
    Prog Clin Biol Res; 1983 Feb; 127():33-42. PubMed ID: 6889403
    [No Abstract] [Full Text] [Related]

  • 8. Spleen iron content is low in thalassemia.
    Borgna-Pignatti C, De Stefano P, Bongo IG, Avato F, Cazzola M.
    Am J Pediatr Hematol Oncol; 1984 Feb; 6(3):340-3. PubMed ID: 6517228
    [Abstract] [Full Text] [Related]

  • 9. Iron absorption in non-transfused iron loading anaemias: prediction of risk for iron loading, and response to iron chelation treatment, in beta thalassaemia intermedia and congenital sideroblastic anaemias.
    Pippard MJ, Weatherall DJ.
    Haematologia (Budap); 1984 Feb; 17(1):17-24. PubMed ID: 6724353
    [Abstract] [Full Text] [Related]

  • 10. Chronic iron overload: new chelators and new strategies.
    Fairbanks VF.
    J Lab Clin Med; 1978 Aug; 92(2):141-3. PubMed ID: 681806
    [No Abstract] [Full Text] [Related]

  • 11. Iron excretion in thalassemia after the administration of chelating agents.
    Markum AH, Iskandar W, Keng KL, Odang O.
    Paediatr Indones; 1969 Aug; 9(3):89-98. PubMed ID: 4981722
    [No Abstract] [Full Text] [Related]

  • 12. Glucose tolerance and chelation therapy in patients with thalassaemia major.
    Capra L, Atti G, De Sanctis V, Candini G.
    Haematologica; 1983 Aug; 68(1):63-8. PubMed ID: 6404709
    [No Abstract] [Full Text] [Related]

  • 13. Management of thalassemia in Los Angeles.
    Hyman CB, Ortega JA, Costin G, Landing B, Lazerson J, Leimbrock S, Lurie P.
    Birth Defects Orig Artic Ser; 1976 Aug; 12(8):43-52. PubMed ID: 1009234
    [No Abstract] [Full Text] [Related]

  • 14. Thalassemia in Britain and Australia.
    Modell B, Matthews R.
    Birth Defects Orig Artic Ser; 1976 Aug; 12(8):13-29. PubMed ID: 795477
    [No Abstract] [Full Text] [Related]

  • 15. Evaluation of desferrioxamine and ascorbic acid for the treatment of chronic iron overload.
    Nienhuis AW, Delea C, Aamodt R, Bartter F, Anderson WF.
    Birth Defects Orig Artic Ser; 1976 Aug; 12(8):177-85. PubMed ID: 795481
    [No Abstract] [Full Text] [Related]

  • 16. Iron overload: pathogenesis and treatment with chelating agents.
    Huebers H.
    Blut; 1983 Aug; 47(2):61-7. PubMed ID: 6871476
    [No Abstract] [Full Text] [Related]

  • 17. Potential usefulness of free radical scavengers in iron overload.
    Graziano JH.
    Birth Defects Orig Artic Ser; 1976 Aug; 12(8):135-43. PubMed ID: 795478
    [No Abstract] [Full Text] [Related]

  • 18. A controlled trial of long-term chelation therapy in homozygous beta-thalassemia.
    Letsky EA.
    Birth Defects Orig Artic Ser; 1976 Aug; 12(8):31-41. PubMed ID: 1009233
    [No Abstract] [Full Text] [Related]

  • 19. Can iron chelators influence the progression of atherosclerosis?
    Marx JJ, Kartikasari AE, Georgiou NA.
    Hemoglobin; 2008 Aug; 32(1-2):123-34. PubMed ID: 18274990
    [Abstract] [Full Text] [Related]

  • 20. Ascorbic acid status in thalassemia major.
    Tagliabue A, Turconi G, Allegrini M, De Stefano P, Borgna-Pignatti C, Bongo I, Dezza L, Cazzola M.
    Haematologica; 1984 Aug; 69(5):542-8. PubMed ID: 6437931
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.